However, in this study, we found that a PPARα agonist could not ameliorate diet-induced hepatic steatosis in Usp25−/− mice, which was inconsistent with the findings of previous studies showing that a PPARα agonist could ameliorate diet-induced hepatic steatosis in wildtype mice (29, 30). The gene discussed is PPARA; the disease is fatty liver disease.